Literature DB >> 15137006

Association between surgical margins and long-term outcome in advanced hepatoblastoma.

Bryan J Dicken1, David L Bigam, Gordon M Lees.   

Abstract

BACKGROUND: Many patients with hepatoblastoma present with unresectable disease. Neoadjuvant therapy has improved resectability rates to as high as 70% to 90%. Despite this improvement, many patients will be left with tumors that are of borderline resectability. The authors hypothesize that favorable outcomes may be achieved even with resection margins less than 1 cm thus sparing the need for liver transplantation.
METHODS: Between January 1981 and March 2003, 23 patients age less than 16 years with a diagnosis of hepatoblastoma undergoing surgical resection were identified. The clinical characteristics, pathologic resection margins, and survival status were reviewed.
RESULTS: Eighteen (78%) of the patients were alive with no evidence of recurrence at last follow-up. Thirteen (56.5%) had > or =1 cm resection margins, whereas 10 (43.5%) had resection margins less than 1 cm. Eleven (47.8%) presented with PRETEXT III tumors. There was no significant difference in survival rate between resection margins less than 1 cm and > or =1 cm (P =.13; 95% CI 0.91 to 2.61). Thirteen patients (56.5%) presented with synchronous pulmonary metastatic disease, where survival was significantly worse (P =.04; 95% CI 1.10 to 2.50). Subgroup analysis confirmed that margins less than 1 cm did not significantly affect survival after controlling for pulmonary metastatic disease (P =.56; 95% CI 0.71 to 3.61).
CONCLUSIONS: Surgical resection with margins less than 1 cm are associated with survival that is equivalent to resection with margins > or =1 cm. Our findings suggest it is preferable to preserve key structures with a small resection margin and therefore spare the need for liver transplantation in patients with advanced hepatoblastoma.

Entities:  

Mesh:

Year:  2004        PMID: 15137006     DOI: 10.1016/j.jpedsurg.2004.01.035

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

1.  Treatment outcomes for hepatoblastoma: an institution's experience over two decades.

Authors:  J P Ang; J A Heath; S Donath; S Khurana; A Auldist
Journal:  Pediatr Surg Int       Date:  2006-11-21       Impact factor: 1.827

Review 2.  Primary malignant liver tumors in children.

Authors:  Sandeep Agarwala
Journal:  Indian J Pediatr       Date:  2012-03-01       Impact factor: 1.967

3.  Current therapeutic strategies for childhood hepatic malignant tumors.

Authors:  Eiso Hiyama
Journal:  Int J Clin Oncol       Date:  2013-09-21       Impact factor: 3.402

Review 4.  The role of liver transplantation in the management of paediatric liver tumours.

Authors:  Mark D Stringer
Journal:  Ann R Coll Surg Engl       Date:  2007-01       Impact factor: 1.891

5.  Clinical applications of computerized tomography 3-D reconstruction imaging for diagnosis and surgery in children with large liver tumors or tumors at the hepatic hilum.

Authors:  Qian Dong; Wenjian Xu; Buxian Jiang; Yun Lu; Xiwei Hao; Hong Zhang; Zhong Jiang; Hongting Lu; Chuanmin Yang; Yu Cheng; Xuedong Yang; Dapeng Hao
Journal:  Pediatr Surg Int       Date:  2007-09-08       Impact factor: 1.827

6.  Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.

Authors:  Rebecka L Meyers; Jon R Rowland; Mark Krailo; Zhengjia Chen; Howard M Katzenstein; Marcio H Malogolowkin
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

7.  Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics.

Authors:  Harold N Lovvorn; Dan Ayers; Zhiguo Zhao; Melissa Hilmes; Pinki Prasad; Myrick C Shinall; Barry Berch; Wallace W Neblett; James A O'Neill
Journal:  J Pediatr Surg       Date:  2010-01       Impact factor: 2.545

Review 8.  How Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the Literature.

Authors:  Roberta Angelico; Chiara Grimaldi; Carlo Gazia; Maria Cristina Saffioti; Tommaso Maria Manzia; Aurora Castellano; Marco Spada
Journal:  Cancers (Basel)       Date:  2019-10-31       Impact factor: 6.639

9.  Histological and immunohistochemical study of hepatoblastoma: correlation with tumour behaviour and survival.

Authors:  Kala Gnanasekaran Kiruthiga; Banumathi Ramakrishna; Soumitra Saha; Sudipta Sen
Journal:  J Gastrointest Oncol       Date:  2018-04

10.  Clinical and Pathological Study of Tumor Border Invasion-Is Narrow Resection Margin Acceptable in Hepatoblastoma Surgery?

Authors:  Gang Shen; Linlin Wu; Jie Zhao; Bin Wei; Xianjun Zhou; Feifei Wang; Jie Liu; Qian Dong
Journal:  Front Med (Lausanne)       Date:  2020-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.